Mucormycosis and chromoblastomycosis occurring in a patient with leprosy type 2 reaction under prolonged corticosteroid and thalidomide therapy

被引:13
作者
Alves Basilio, Flavia Machado [1 ]
Hammerschmidt, Mariana [1 ]
Mukai, Maira Mitsue [1 ]
Werner, Betina [1 ]
Pinheiro, Rosangela Lameira [1 ]
Moritz, Sandra [1 ]
机构
[1] Univ Fed Parana HC UFPR, Teaching Hosp, Hosp Clin, Curitiba, Parana, Brazil
关键词
Chromoblastomycosis; Immunocompromised host; Leprosy; Mucormycosis; FONSECAEA-PEDROSOI; MANAGEMENT;
D O I
10.1590/S0365-05962012000500017
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Mucormycosis is an uncommon fungal infection caused by Mucorales. It frequently occurs in patients with neutropenia, diabetes, malignancy and on corticoid therapy. However, it is rare in patients with AIDS. Clinical disease can be manifested in several forms. The case reported illustrates the rare occurrence of chromoblastomycosis and mucormycosis in an immunosuppressed patient with multibacillary leprosy, under prolonged corticosteroid and thalidomide therapy to control leprosy type 2 reaction. Neutrophil dysfunction, thalidomide therapy and work activities are some of the risk factors in this case. Chromoblastomycosis was treated by surgical excision and mucormycosis with amphotericin B. Although the prognosis of mucormycosis is generally poor, in the reported case the patient recovered successfully. This case should alert dermatologists to possible opportunistic infections in immunosuppressed patients.
引用
收藏
页码:767 / 771
页数:5
相关论文
共 10 条
[1]   Chromoblastomycosis Caused by Fonsecaea pedrosoi [J].
Kim, Dong Min ;
Hwang, Sung Min ;
Suh, Moo Kyu ;
Ha, Gyoung Yim ;
Choi, Gwang Seong ;
Shin, Jeonghyun ;
Han, Sung Hyub .
ANNALS OF DERMATOLOGY, 2011, 23 (03) :369-374
[2]   Zygomycosis in the 1990s in a tertiary-care cancer center [J].
Kontoyiannis, DP ;
Wessel, VC ;
Bodey, GP ;
Rolston, KVI .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (06) :851-856
[3]   Activity of Deferasirox in Mucorales: Influences of Species and Exogenous Iron [J].
Lewis, Russell E. ;
Pongas, Georgios N. ;
Albert, Nathaniel ;
Ben-Ami, Ronen ;
Walsh, Thomas J. ;
Kontoyiannis, Dimitrios P. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (01) :411-413
[4]   Mucormycosis in systemic lupus erythematosus [J].
Mok, CC ;
Que, TL ;
Tsui, EYK ;
Lam, WY .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2003, 33 (02) :115-124
[5]   Primary cutaneous mucormycosis in infants and neonates: Case report and review of the literature [J].
Oh, D ;
Notrica, D .
JOURNAL OF PEDIATRIC SURGERY, 2002, 37 (11) :1607-1611
[6]   Beneficial Effects of HIV Peptidase Inhibitors on Fonsecaea pedrosoi: Promising Compounds to Arrest Key Fungal Biological Processes and Virulence [J].
Palmeira, Vanila F. ;
Kneipp, Lucimar F. ;
Rozental, Sonia ;
Alviano, Celuta S. ;
Santos, Andre L. S. .
PLOS ONE, 2008, 3 (10)
[7]   Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment [J].
Queiroz-Telles, Flavio ;
Esterre, Phillippe ;
Perez-Blanco, Maigualida ;
Vitale, Roxana G. ;
Salgado, Claudio Guedes ;
Bonifaz, Alexandro .
MEDICAL MYCOLOGY, 2009, 47 (01) :3-15
[8]   Recent Advances in the Management of Mucormycosis: From Bench to Bedside [J].
Spellberg, Brad ;
Walsh, Thomas J. ;
Kontoyiannis, Dimitrios P. ;
Edwards, John, Jr. ;
Ibrahim, Ashraf S. .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (12) :1743-1751
[9]   Mucormycosis: its contemporary face and management strategies [J].
Sun, Hsin-Yun ;
Singh, Nina .
LANCET INFECTIOUS DISEASES, 2011, 11 (04) :301-311
[10]  
Yeung C K, 2001, Hong Kong Med J, V7, P180